Important note

This AI stock analysis for Atricure is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Atricure - AI Stock Analysis

Analysis generated February 23, 2025

Atricure, Inc. is a leading provider of innovative solutions designed to reduce the risk of stroke in patients with atrial fibrillation (AFib), a condition characterized by an irregular and often rapid heart rate. The company focuses on developing, manufacturing, and selling technologies that help to treat AFib and related conditions through minimally invasive procedures. Key offerings include advanced ablation devices, clip-based solutions, and ancillary products that address different stages and types of AFib. The company has shown a commitment to improving patient outcomes and setting a standard in the medical industry for AFib treatment.

Fundamental Analysis

Revenue for the last quarter was $116 million. This represents a slight decrease of 0.31% compared to the previous quarter, indicating a potential area of concern. However, when compared to the same quarter last year, there is an increase of 17.93%, suggesting that the company is experiencing significant year-over-year growth.

Net income for the last quarter was $7.9 million. This is an increase of 1.94% compared to the previous quarter, which is a positive indicator of continuous growth. Compared to the same quarter last year, there is an increase of 13.27%, underscoring solid year-over-year profit growth.

EBITDA for the last quarter was $5.3 million. This is a strong increase of 25.24% compared to the previous quarter, signaling operational efficiency and growth. Compared to the same quarter last year, there is an increase of 0.36%, suggesting stable operational performance on a yearly basis.

Technical Analysis

Today's stock price for Atricure is $38.39. This marks a decrease of 4.90% over the last month, which may be concerning for short-term investors. However, on a year-over-year basis, the stock price has increased by 14.39%, indicating a positive long-term trend.

The current trend is bearish as the stock price has been struggling to gain ground. The current SMA10 is $39.53, which is marginally lower than the previous SMA10 of $39.65. This slight decrease hints at a potential short-term downward trend in price movement.

The Relative Strength Index (RSI) is at 68.1, indicating a neutral condition. This value is approaching the overbought threshold but is not yet in the critical zone, suggesting neither strong buy nor sell signals at the moment.

Alternative Data Analysis

Atricure currently has 76 open positions listed on popular job boards. This number represents a 52% increase in job postings over the last couple of months, indicating the company’s intention to expand and grow, which is a positive indicator for future performance.

Employee sentiment is also extremely high, with about 94% of employees having a positive outlook on the company’s future, which is a very encouraging sign for potential investors.

However, customer acquisition data reveals some concerns. Atricure's website has recorded approximately 13,000 visitors, but this number is down by 46% over the last couple of months. This worrisome trend could suggest a decline in customer interest or engagement over the short term.

On social media, Atricure has 790 followers on Instagram (a 3% increase in the last couple of months) and 2,600 followers on Twitter with no significant changes. While there's a modest growth on Instagram, the static status on Twitter may indicate limited engagement through social media channels.

Lastly, according to AltIndex's AI score, which predicts stock performance using fundamental, technical, and alternative data, Atricure has a score of 71, generally considered a buy signal.

Conclusion and Recommendation

Atricure presents a strong case for long-term investment based on its solid year-over-year revenue and net income growth. The current increase in EBITDA and robust employee sentiment are positive indicators for the company. However, the declining short-term stock price and website visitor numbers suggest some areas that prospective investors need to watch closely. Given the long-term upward trend and the positive AI score from AltIndex, prospective investors may consider Atricure a worthwhile investment with potential for growth, particularly if the company can address its short-term challenges.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.